Lineage Cell Therapeutics In

Small-Cap Stocks Penny Stocks Biotech Stocks Healthcare Stocks

$1.21

-0.04 (-3.20%)

As of Jun 21, 10:24 PM ET ·

Analyst Consensus

Strong Buy

Analysts

Moderate

Coverage

Buy 11 85%

Hold 2 15%

Sell 0 0%

Price Target

Analyst Price Target +3,240.5% upside

Low Target $29.91

Average Target $40.42

High Target $53.83

Current Price $1.21

Current
$1.21

Target
$40.42

$29.91 $40.42 avg $53.83

Scenario Analysis

Bear Case

$29.91

2,371.9%

Low target

Base Case

$40.42

+3,240.5%

Avg target

Bull Case

$53.83

+4,348.8%

High target

Risk/Reward

1.8x

Balanced

Price in Context

52-Week High

$2.09

-42.1% from high

52-Week Low

$0.83

+45.8% from low

Target vs 52W High

$40.42

+1,834.0% vs high

Peer Consensus — Biotechnology

Stock	Consensus	Analysts	Buy %	Target	Upside
ABBV Abbvie Inc	Strong Buy	40	78%	$257.58	+9.7%
AMGN Amgen Inc	Hold	44	50%	$190.87	-45.0%
GILD Gilead Sciences Inc	Strong Buy	39	82%	$362.68	+190.0%
VRTX Vertex Pharmaceuticals Inc	Strong Buy	40	83%	$438.34	-6.4%
REGN Regeneron Pharmaceuticals	Buy	38	71%	$76.80	-87.6%
ALNY Alnylam Pharmaceuticals Inc	Strong Buy	37	76%	$102.31	-64.5%
RVMD Revolution Medicines Inc	Strong Buy	27	96%	$114.11	-32.7%
NTRA Natera Inc	Strong Buy	27	89%	$142.91	-39.1%